135 related articles for article (PubMed ID: 25243873)
21. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
22. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
23. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
[TBL] [Abstract][Full Text] [Related]
24. Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro.
Liu HL; Chen Y; Cui GH; Wu QL; He J
Acta Pharmacol Sin; 2005 Jul; 26(7):873-80. PubMed ID: 15960896
[TBL] [Abstract][Full Text] [Related]
25. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
Zhang C; Zhao Y; Zeng B
Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
27. Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line.
Sano J; Nagafuchi S; Yamazaki J; Oguma K; Kano R; Hasegawa A
Res Vet Sci; 2005 Dec; 79(3):197-201. PubMed ID: 15893350
[TBL] [Abstract][Full Text] [Related]
28. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
29. Citral in lemon myrtle, lemongrass, litsea, and melissa essential oils suppress the growth and invasion of breast cancer cells.
Nagata T; Satou T; Hayashi S; Satyal P; Watanabe M; Riggs B; Saida Y
BMC Complement Med Ther; 2024 Jun; 24(1):211. PubMed ID: 38831283
[TBL] [Abstract][Full Text] [Related]
30. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
32. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Luo D; Cheng SC; Xie H; Xie Y
Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
[TBL] [Abstract][Full Text] [Related]
33. HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells.
Skommer J; Wlodkowic D; Mättö M; Eray M; Pelkonen J
Leuk Res; 2006 Mar; 30(3):322-31. PubMed ID: 16213584
[TBL] [Abstract][Full Text] [Related]
34. Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.
Zeng S; Kapur A; Patankar MS; Xiong MP
Pharm Res; 2015 Aug; 32(8):2548-58. PubMed ID: 25673043
[TBL] [Abstract][Full Text] [Related]
35. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
36. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
[TBL] [Abstract][Full Text] [Related]
37. Combination Treatment of Citral Potentiates the Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with Pirarubicin for Colorectal Cancer.
Fang Z; Wang Y; Li H; Yu S; Liu Z; Fan Z; Chen X; Wu Y; Pan X; Li X; Wang C
Mol Pharm; 2017 Oct; 14(10):3588-3597. PubMed ID: 28841022
[TBL] [Abstract][Full Text] [Related]
38. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin.
Xu Y; Zheng W; Wang T; Wang P; Zhu L; Ma X
Biomed Pharmacother; 2012 Jul; 66(5):368-72. PubMed ID: 22560635
[TBL] [Abstract][Full Text] [Related]
39. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2.
Weecharangsan W; Lee RJ
Drug Deliv; 2012 Aug; 19(6):292-7. PubMed ID: 22931245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]